Plasma membrane proteome analysis of the early effect of alcohol on liver: Implications for alcoholic liver disease

Acta Biochimica et Biophysica Sinica

Volumn 43, Issue 1, 2011, Pages 19-29

  Zhang, Lijun ^a,b   Jia, Xiaofang ^a   Feng, Yanling ^a   Peng, Xia ^a   Zhang, Zhiyong ^a   Zhou, Wenjiang ^a   Zhang, Zhanqing ^a   Ma, Fang ^a   Liu, Xiaohui ^a   Zheng, Ye ^a   Yang, Pengyuan ^a   Yuan, Zhenghong ^a  

^a FUDAN UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

2 DE MS; alcohol; iTRAQ; keratin 18; liver fibrosis

Indexed keywords

ALCOHOL; CYTOKERATIN 18; CYTOKERATIN 8; LIPOCORTIN 2; PROTEOME;

ALCOHOL LIVER DISEASE; ANIMAL; ARTICLE; CELL MEMBRANE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; LIVER; LIVER CIRRHOSIS; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANNEXIN A2; CELL MEMBRANE; ETHANOL; KERATIN-18; KERATIN-8; LIVER; LIVER CIRRHOSIS; LIVER DISEASES, ALCOHOLIC; MALE; PROTEOME; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 78650749869     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmq108     Document Type: Article

References (43)

1. Szabo G and Bala S. Alcoholic liver disease and the gut-liver axis. World J Gastroenterol 2010, 16: 1321-1329.
2. Mello T, Ceni E, Surrenti C and Galli A. Alcohol induced hepatic fibrosis: role of acetaldehyde. Mol Aspects Med 2008, 29: 17-21.
3. Forgione A, Miele L, Cefalo C, Gasbarrini G and Grieco A. Alcoholic and nonalcoholic forms of fatty liver disease. Minerva Gastroenterol Dietol 2007, 53: 83-100.
4. Kudo T, Tamagawa T and Shibata S. Effect of chronic ethanol exposure on the liver of Clock-mutant mice. J Circadian Rhythms 2009, 7: 4.
5. Gressner AM, Gao CF and Gressner OA. Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey. World J Gastroenterol 2009, 15: 2433-2440.
6. French SW. Ethanol and hepatocellular injury. Clin Lab Med 1996, 16: 289-306.
7. Losser MR and Payen D. Mechanisms of liver damage. Semin Liver Dis 1996, 16: 357-367.
8. Adachi J, Asano M, Ueno Y, Niemela O, Ohlendieck K, Peters TJ and Preedy VR. Alcoholic muscle disease and biomembrane perturbations (review). J Nutr Biochem 2003, 14: 616-625.
9. Pedersen SK, Harry JL, Sebastian L, Baker J, Traini MD, McCarthy JT and Manoharan A, et al. Unseen proteome: mining below the tip of the iceberg to find low abundance and membrane proteins. J Proteome Res 2003, 2: 303-311.
10. Mannova P, Fang R, Wang H, Deng B, McIntosh MW, Hanash SM and Beretta L. Modification of host lipid raft proteome upon hepatitis C virus replication. Mol Cell Proteomics 2006, 5: 2319-2325.
11. de Laurentiis A, Donovan L and Arcaro A. Lipid rafts and caveolae in signaling by growth factor receptors. Open Biochem J 2007, 1: 12-32.
12. Pizarro-Cerda J and Cossart P. Bacterial adhesion and entry into host cells. Cell 2006, 124: 715-727.
13. Dietz A, Logothetis CA, Helbig M, Flechtenmacher C, Rudat V, Dollner R and Wallner F, et al. Prognostic impact of EBV-related LMP-1, histo-logic type, and environmental factors in nasopharyngeal carcinoma in a German population. Onkologie 2004, 27: 345-350.
14. Lai ZW, Steer DL and Smith AI. Membrane proteomics: the development of diagnostics based on protein shedding. Curr Opin Mol Ther 2009, 11: 623-631.
15. Nomura F, Tomonaga T, Sogawa K, Wu D and Ohashi T. Application of proteomic technologies to discover and identify biomarkers for excessive alcohol consumption: a review. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 855: 35-41.
16. Hwang SI, Lundgren DH, Mayya V, Rezaul K, Cowan AE, Eng JK and Han DK. Systematic characterization of nuclear proteome during apopto-sis: a quantitative proteomic study by differential extraction and stable isotope labeling. Mol Cell Proteomics 2006, 5: 1131-1145.
17. Adams JC, Clelland JD, Collett GD, Matsumura F, Yamashiro S and Zhang L. Cell-matrix adhesions differentially regulate fascin phosphoryl-ation. Mol Biol Cell 1999, 10: 4177-4190.
18. Wang L, Ji G, Zheng PY and Long AH. Establishment of a rat model of alcoholic liver fibrosis induced by complex factors. Zhong Xi Yi Jie He Xue Bao 2006, 4: 281-284.
19. Zhang L, Peng X, Zhang Z, Feng Y, Jia X, Shi Y and Yang H, et al. Subcellular proteome analysis unraveled annexin A2 related to immune liver fibrosis. J Cell Biochem 2010, 111: 219-228.
20. Zhang L, Jia X, Zhang X, Sun J, Peng X, Qi T and Ma F, et al. Proteomic analysis of PBMCs: characterization of potential HIV-associated proteins. Proteome Sci 2010, 8: 12.
21. Zhang LJ, Wang XE, Peng X, Wei YJ, Cao R, Liu Z and Xiong JX, et al. Proteomic analysis of low-abundant integral plasma membrane proteins based on gels. Cell Mol Life Sci 2006, 63: 1790-1804.
22. Jin J, Park J, Kim K, Kang Y, Park SG, Kim JH and Park KS, et al. Detection of differential proteomes of human beta-cells during islet-like differentiation using iTRAQ labeling. J Proteome Res 2009, 8: 1393-1403.
23. Guo Y, Singleton PA, Rowshan A, Gucek M, Cole RN, Graham DR and Van Eyk JE, et al. Quantitative proteomics analysis of human endothelial cell membrane rafts: evidence of MARCKS and MRP regulation in the sphingosine 1-phosphate-induced barrier enhancement. Mol Cell Proteomics 2007, 6: 689-696.
24. Zhang Z, Zhang L, Hua Y, Jia X, Li J, Hu S and Peng X, et al. Comparative proteomic analysis of plasma membrane proteins between human osteosarcoma and normal osteoblastic cell lines. BMC Cancer 2010, 10: 206-207.
25. Shilov IV, Seymour SL, Patel AA, Loboda A, Tang WH, Keating SP and Hunter CL, et al. The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics 2007, 6: 1638-1655.
26. Molleken C, Sitek B, Henkel C, Poschmann G, Sipos B, Wiese S and Warscheid B, et al. Detection of novel biomarkers of liver cirrhosis by proteomic analysis. Hepatology 2009, 49: 1257-1266.
27. Spano D, Cimmino F, Capasso M, D'Angelo F, Zambrano N, Terracciano L and Iolascon A. Changes of the hepatic proteome in hepatitis B-infected mouse model at early stages of fibrosis. J Proteome Res 2008, 7: 2642-2653.
28. Gangadharan B, Antrobus R, Dwek RA and Zitzmann N. Novel serum biomarker candidates for liver fibrosis in hepatitis C patients. Clin Chem 2007, 53: 1792-1799.
29. Cheung KJ, Tilleman K, Deforce D, Colle I and Van Vlierberghe H. Proteomics in liver fibrosis is more than meets the eye. Eur J Gastroenterol Hepatol 2008, 20: 450-464.
30. Zhang L, Xie J, Wang X, Liu X, Tang X, Cao R and Hu W, et al. Proteomic analysis of mouse liver plasma membrane: use of differential extraction to enrich hydrophobic membrane proteins. Proteomics 2005, 5: 4510-4524.
31. Martyniuk CJ and Denslow ND. Towards functional genomics in fish using quantitative proteomics. Gen Comp Endocrinol 2009, 164: 135-141.
32. Latterich M, Abramovitz M and Leyland-Jones B. Proteomics: new technologies and clinical applications. Eur J Cancer 2008, 44: 2737-2741.
33. Aggarwal K, Choe LH and Lee KH. Shotgun proteomics using the iTRAQ isobaric tags. Brief Funct Genomic Proteomic 2006, 5: 112-120.
34. Bagshaw RD, Mahuran DJ and Callahan JW. A proteomic analysis of lysosomal integral membrane proteins reveals the diverse composition of the organelle. Mol Cell Proteomics 2005, 4: 133-143.
35. Goldring CE, Kitteringham NR, Jenkins R, Lovatt CA, Randle LE, Abdullah A and Owen A, et al. Development of a transactivator in hepa-toma cells that allows expression of phase I, phase II, and chemical defense genes. Am J Physiol Cell Physiol 2006, 290: C104-115.
36. Seth D, Hogg PJ, Gorrell MD, McCaughan GW and Haber PS. Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease. J Hepatol 2008, 48: 614-627.
37. Seth D, Leo MA, McGuinness PH, Lieber CS, Brennan Y, Williams R and Wang XM, et al. Gene expression profiling of alcoholic liver disease in the baboon (Papio hamadryas) and human liver. Am J Pathol 2003, 163: 2303-2317.
38. Ku NO, Strnad P, Zhong BH, Tao GZ and Omary MB. Keratins let liver live: mutations predispose to liver disease and crosslinking generates Mallory-Denk bodies. Hepatology 2007, 46: 1639-1649.
39. Butura A, Nilsson K, Morgan K, Morgan TR, French SW, Johansson I and Schuppe-Koistinen I, et al. The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model. J Hepatol 2009, 50: 572-583.
40. Kim JK, Bamba T, Harada K, Fukusaki E and Kobayashi A. Time-course metabolic profiling in Arabidopsis thaliana cell cultures after salt stress treatment. J Exp Bot 2007, 58: 415-424.
41. Strnad P, Lienau TC, Tao GZ, Lazzeroni LC, Stickel F, Schuppan D and Omary MB. Keratin variants associate with progression of fibrosis during chronic hepatitis C infection. Hepatology 2006, 43: 1354-1363.
42. Toivola DM, Ku NO, Resurreccion EZ, Nelson DR, Wright TL and Omary MB. Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease. Hepatology 2004, 40: 459-466.
43. Cohen AA, Geva-Zatorsky N, Eden E, Frenkel-Morgenstern M, Issaeva I, Sigal A and Milo R, et al. Dynamic proteomics of individual cancer cells in response to a drug. Science 2008, 322: 1511-1516.